Mark Douglas
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 7
- Chronic Lymphocytic Leukemia Research 7
-
- Lymphoma Diagnosis and Treatment 4
- Co-authors
- Patrick Francis Kelly (7 shared papers)Kerstin R. Allen (7 shared papers)Steven Horwitz (7 shared papers)Jennifer Sweeney (6 shared papers)Howard Marvin Stern (9 shared papers)Pierluigi Porcu (4 shared papers)Virginia M. Kelly (4 shared papers)Yasuhiro Oki (4 shared papers)
- Journals
- Blood (6 papers)Fuel (2 papers)American Journal of Hematology (2 papers)Molecular Cancer Therapeutics (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Mark Douglas
18 papers receiving 1.6k citations
Mark Douglas's Hit Papers
Peers
Comparison fields: 5 of 67
- Genetics 238
- Pathology and Forensic Medicine 300
- Oncology 366
- Immunology 317
- Dermatology 61
Countries citing papers authored by Mark Douglas
This map shows the geographic impact of Mark Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Douglas more than expected).
Fields of papers citing papers by Mark Douglas
This network shows the impact of papers produced by Mark Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Douglas. The network helps show where Mark Douglas may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Douglas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells Hit paper breakdown → | 2016 | 723 |
| 2 | 2017 | 248 | |
| 3 | 2017 | 212 | |
| 4 | 2012 | 68 | |
| 5 | 2007 | 59 | |
| 6 | 2016 | 57 | |
| 7 | 2018 | 51 | |
| 8 | 2014 | 42 | |
| 9 | 2014 | 41 | |
| 10 | 2018 | 32 | |
| 11 | 2007 | 29 | |
| 12 | 2014 | 21 | |
| 13 | 2014 | 15 | |
| 14 | 2009 | 14 | |
| 15 | Characterization of deinking sludge and its ashed residue | 1994 | 11 |
| 16 | Combustion of paper deinking solids in a pilot-scale fluidized bed | 1994 | 6 |
| 17 | 2013 | 3 | |
| 18 | 1986 | 2 | |
| 19 | 2010 | 1 |
About Mark Douglas
Mark Douglas is a scholar working on Genetics, Pathology and Forensic Medicine, Health, Toxicology and Mutagenesis, Mechanical Engineering and Waste Management and Disposal, having authored 19 papers that have together received 1.6k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (4 papers), Heat shock proteins research (3 papers), Industrial Gas Emission Control (2 papers), Mercury impact and mitigation studies (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Granular flow and fluidized beds (1 paper) and RNA and protein synthesis mechanisms (1 paper). The work is most often cited by research in Genetics (238 citations), Pathology and Forensic Medicine (300 citations), Oncology (366 citations), Immunology (317 citations) and Dermatology (61 citations). Mark Douglas has collaborated with scholars based in United States and Canada. Frequent co-authors include Patrick Francis Kelly, Kerstin R. Allen, Steven Horwitz, Jennifer Sweeney, Howard Marvin Stern, Pierluigi Porcu, Virginia M. Kelly, Yasuhiro Oki, Brad S. Kahl and Ian W. Flinn. Their work appears in journals such as Blood, Fuel, American Journal of Hematology, Molecular Cancer Therapeutics and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.